BPU17, CAS [[2198977-68-1]]

Produktübersicht

• Artikelname: BPU17, CAS [[2198977-68-1]]
• Artikelnummer: MCE-HY-162904
• Hersteller Artikelnummer: HY-162904
• Alternativnummer: MCE-HY-162904-5MG,MCE-HY-162904-100MG,MCE-HY-162904-10MG,MCE-HY-162904-50MG,MCE-HY-162904-25MG,MCE-HY-162904-250MG,MCE-HY-162904-500MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

BPU17 binds to PHB1 and causes mild defects in mitochondrial function by defects in the PHB1-PHB2 interaction. This impairment inhibits the SRF/CArG-box-dependent transcription, resulting in the suppression of epithelial-mesenchymal transition (EMT) of retinal pigment epithelial cells (RPEs). BPU17 exhibits antifibrotic activity in vivo. BPU17 is promising for research of anti-neovascular age-related macular degeneration (nAMD) agent[1].

Produkteigenschaften

• Molekulargewicht: 252.70
• Reinheit: 98.16
• CAS Nummer: [2198977-68-1]
• Formel: C12H13ClN2O2
• Target-Kategorie: Mitochondrial Metabolism

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound